Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) EBT Margin (2016 - 2019)

Phio Pharmaceuticals' EBT Margin history spans 8 years, with the latest figure at 10219.05% for Q1 2019.

  • For Q1 2019, EBT Margin fell 48427.0% year-over-year to 10219.05%; the TTM value through Dec 2019 reached 42795.24%, down 3746190.0%, while the annual FY2024 figure was 2954.8%, 11731187.0% up from the prior year.
  • EBT Margin reached 10219.05% in Q1 2019 per PHIO's latest filing, down from 2619.3% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 2619.3% in Q3 2018 to a low of 24577.78% in Q2 2016.
  • Average EBT Margin over 5 years is 11843.37%, with a median of 9976.92% recorded in 2018.
  • Peak YoY movement for EBT Margin: tumbled -1364824bps in 2016, then tumbled -48427bps in 2019.
  • A 5-year view of EBT Margin shows it stood at 8661.76% in 2015, then plummeted by -184bps to 24577.78% in 2016, then skyrocketed by 46bps to 13346.67% in 2017, then soared by 80bps to 2619.3% in 2018, then tumbled by -290bps to 10219.05% in 2019.
  • Per Business Quant, the three most recent readings for PHIO's EBT Margin are 10219.05% (Q1 2019), 2619.3% (Q3 2018), and 3277.59% (Q2 2018).